A detailed history of Lazard Asset Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 65,764 shares of INCY stock, worth $4.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
65,764
Previous 66,920 1.73%
Holding current value
$4.88 Million
Previous $4.06 Million 7.17%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$57.33 - $68.61 $66,273 - $79,313
-1,156 Reduced 1.73%
65,764 $4.35 Million
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $297,202 - $370,196
-5,807 Reduced 7.98%
66,920 $4.06 Million
Q1 2024

May 14, 2024

BUY
$56.55 - $66.59 $535,924 - $631,073
9,477 Added 14.98%
72,727 $4.14 Million
Q4 2023

Feb 14, 2024

SELL
$52.16 - $64.19 $1.88 Million - $2.31 Million
-36,048 Reduced 36.3%
63,250 $3.97 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $5.06 Million - $5.77 Million
87,560 Added 745.95%
99,298 $5.74 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $2.16 Million - $2.68 Million
-35,471 Reduced 75.14%
11,738 $730,000
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $2.25 Million - $2.75 Million
32,008 Added 210.57%
47,209 $3.41 Million
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $915,394 - $1.15 Million
-13,626 Reduced 47.27%
15,201 $1.22 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $197,812 - $247,668
2,989 Added 11.57%
28,827 $1.92 Million
Q2 2022

Aug 09, 2022

SELL
$66.18 - $83.18 $3.96 Million - $4.97 Million
-59,796 Reduced 69.83%
25,838 $1.96 Million
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $711,761 - $859,353
-10,781 Reduced 11.18%
85,634 $6.8 Million
Q4 2021

Feb 09, 2022

BUY
$63.34 - $74.11 $5.68 Million - $6.65 Million
89,728 Added 1341.83%
96,415 $7.08 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $149,425 - $182,827
2,176 Added 48.24%
6,687 $459,000
Q2 2021

Aug 12, 2021

SELL
$79.87 - $87.53 $476,744 - $522,466
-5,969 Reduced 56.96%
4,511 $379,000
Q1 2021

May 14, 2021

BUY
$76.02 - $100.5 $159,946 - $211,452
2,104 Added 25.12%
10,480 $851,000
Q4 2020

Feb 11, 2021

SELL
$80.74 - $97.7 $1.16 Million - $1.4 Million
-14,369 Reduced 63.17%
8,376 $728,000
Q3 2020

Nov 13, 2020

SELL
$85.07 - $109.69 $1.06 Million - $1.37 Million
-12,513 Reduced 35.49%
22,745 $2.04 Million
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $2.26 Million - $3.31 Million
30,410 Added 627.27%
35,258 $3.66 Million
Q1 2020

May 14, 2020

BUY
$63.18 - $85.97 $17,311 - $23,555
274 Added 5.99%
4,848 $354,000
Q4 2019

Feb 13, 2020

BUY
$73.04 - $95.72 $49,959 - $65,472
684 Added 17.58%
4,574 $398,000
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $147,460 - $175,203
2,025 Added 108.58%
3,890 $288,000
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $137,114 - $165,425
1,865 New
1,865 $158,000
Q2 2018

Aug 13, 2018

SELL
$60.85 - $83.98 $60,850 - $83,980
-1,000 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$83.06 - $100.98 $1,495 - $1,817
-18 Reduced 1.77%
1,000 $83,000
Q3 2017

Nov 13, 2017

SELL
$109.15 - $138.27 $4.34 Million - $5.49 Million
-39,723 Reduced 97.5%
1,018 $118,000
Q2 2017

Aug 19, 2019

BUY
N/A
19,010 Added 87.48%
40,741 $5.13 Million
Q1 2017

Aug 13, 2019

BUY
N/A
6,669 Added 44.28%
21,731 $2.9 Million
Q4 2016

Jul 30, 2019

BUY
N/A
14,062 Added 1406.2%
15,062 $1.51 Million
Q2 2016

Jul 29, 2019

SELL
N/A
-1,000 Reduced 50.0%
1,000 $79,000
Q1 2016

Jul 25, 2019

BUY
N/A
2,000
2,000 $144,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.